MedTrace Logo

Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

NCT04590144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 446

Last updated 2025-07-24

No results posted yet for this study

Summary

The primary objective of this study is to assess the safety and key electrical performance of the INVICTA leads equipped with DF4 connector: ACTIVE fixation type models (single and dual coil: INVICTA 1CR, INVICTA 2CR)

Conditions

Interventions

DEVICE

INVICTA lead

The implant or the attempt to implant an INVICTA lead

Sponsors & Collaborators

  • MicroPort CRM

    lead INDUSTRY

Principal Investigators

  • Pedro Marques, MD · Hospital de Santa Maria - Lisboa - Portugal

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2022-03-16
Completion
2024-12-23

Countries

  • Austria
  • France
  • Germany
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590144 on ClinicalTrials.gov